SHANGHAI JINHE BIO-PHARMACEUTICAL CO.,LTD

About SHANGHAI JINHE BIO-PHARMACEUTICAL CO.,LTD

Shanghai Jinhe Bio-Pharmaceutical Co., Ltd. is a pharmaceutical enterprise dedicated to R&D, manufacturing and marketing anti-cancer APIs and their intermediates. We successfully developed Paclitaxel, Docetaxel, Irinotecan, Etoposide, Cabazitaxel, Palonosetron hydrochloride etc. In January 2017, we achieved GMP certificate on Bulk Drug (Paclitaxel, Docetaxel).

  • CN
  • 2016
    On CPHI since
Contact info
Meet us at

CPHI & PMEC China 2024

Shanghai New International Expo Center
19 - 21 June 2024

Products from SHANGHAI JINHE BIO-PHARMACEUTICAL CO.,LTD (5)